4//SEC Filing
Chan Heng Fai Ambrose 4
Accession 0001641172-25-026292
CIK 0000771999other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:43 PM ET
Size
6.4 KB
Accession
0001641172-25-026292
Insider Transaction Report
Form 4
DSS, INC.DSS
CHAN FAI
Director10% Owner
Transactions
- Sale
Common Stock
2025-08-28$1.35/sh+130,679$176,090→ 1,053,796 total
Footnotes (2)
- [F1]On August 28, 2025, Mr. Chan sold 130,679 shares of the Issuer's common stock at an average sale price of $1.3475. The shares were sold in multiple trades at prices ranging between $1.23 and $1.565. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The beneficial ownership of Mr. Chan may be deemed to include the following: (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,053,796 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.).
Documents
Issuer
DSS, INC.
CIK 0000771999
Entity typeother
Related Parties
1- filerCIK 0001261725
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 9:43 PM ET
- Size
- 6.4 KB